Spotlight Asset Group’s Gilead Sciences GILD Stock Holding History

Spotlight Asset Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$2.06M	Hold	30,000	–	–	1.44%	15
2024 Q1	$2.2M	Hold	30,000	–	–	1.57%	14
2023 Q4	$2.25M	Hold	30,000	–	–	2.04%	13
2023 Q3	$2.25M	Hold	30,000	–	–	2.04%	13
2023 Q2	$2.31M	Hold	30,000	–	–	2.07%	13
2023 Q1	$2.03M	Buy	+30,000	New	+$2.48M	2.02%	13
2022 Q3	$2.03M	Buy	+30,000	New	+$1.89M	2.02%	13
2021 Q3	$2.13M	Hold	30,490	–	–	1.06%	23
2021 Q2	$2.1M	Sell	30,490 -2,200	-7%	-$147K	0.81%	26
2021 Q1	$2.11M	Hold	32,690	–	–	0.79%	27
2020 Q4	$1.91M	Sell	32,690 -3,052	-9%	-$184K	0.71%	25
2020 Q3	$2.26M	Hold	35,742	–	–	0.89%	18
2020 Q2	$2.75M	Sell	35,742 -666	-2%	-$51K	1.15%	17
2020 Q1	$2.72M	Buy	36,408 +666	+2%	+$46K	1.45%	18
2019 Q4	$2.63M	Buy	+35,742	New	+$2.33M	1.25%	19

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Spotlight Asset Group's GILD Position: Q2 2024 in Review

Spotlight Asset Group held its Gilead Sciences (GILD) position steady in Q2 2024 at 30,000 shares worth $2.06M. The position accounts for 1.44% of the portfolio, ranked #15.

Spotlight Asset Group first reported a position in GILD in Q4 2019 and has held it in 15 quarters since. The position peaked at $2.75M in Q2 2020. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Spotlight Asset Group held 30,000 shares of Gilead Sciences worth $2.06M as of Q2 2024.
Spotlight Asset Group left its Gilead Sciences share count unchanged in Q2 2024.
Gilead Sciences made up 1.44% of Spotlight Asset Group's portfolio in Q2 2024, its #15 holding.
Spotlight Asset Group first reported a position in Gilead Sciences in Q4 2019 and has held it in 15 quarters since.
Spotlight Asset Group's Gilead Sciences position peaked at $2.75M in Q2 2020.
1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Spotlight Asset Group's 13F filing for Q2 2024, filed 24 Jul 2024.